Introduction
Blood transfusion is a critical application for treatment in some clinical conditions such as trauma, surgical operations, and bleeding diathesis. Therefore, blood banks are indispensable centers to supply various blood products to sufferers. One of the most important problems in blood banks is that blood products have short storage time. As time passes, a number of biochemical changes occur in stored blood, leading to ineffective blood transfusion. Therefore, protecting both the longevity and quality of stored blood is clinically important and many studies are performed to increase the effectiveness of transfusion (1) (2) (3) (4) .
Whole blood collected from donors is composed of erythrocytes, platelets, clotting factors, and plasma. Stored blood includes about 200 mL of erythrocytes, 250 mL of plasma, and 63 mL of preservative solution per unit. The efficiency of whole blood transfusion is evaluated according to the reflected ratio of infused total erythrocyte numbers to circulation of the recipient 24 h after transfusion. This ratio must be at least 75% of the infused number of erythrocytes that determines the shelf life of stored blood (5) .
Various preservative solutions containing anticoagulants and preservative agents are used in order to inhibit coagulation and maintain the viability of stored blood. These additional substituents provide the storage life for 21 to 42 days at 1 to 6 °C in blood banks. Citrate (anticoagulation), sodium biphosphate (protecting 2,3-diphosphoglycerate levels), dextrose, and adenine (ATP source) may be mentioned among these agents and substituents (6, 7) .
Currently, further studies about preservative solutions increasing the life of stored blood are being designed and performed. Hyperbaric oxygen (HBO) therapy, based on 100% oxygen exposure at a level of pressure higher than normal atmospheric pressure, is an established modality in the treatment of many disorders and has been successfully used in clinical conditions related to ischemia and/or hypoxia (8) . The feature of enhancing tissue oxygenation is HBO treatment's most prominent feature by increasing dissolved oxygen levels in plasma. Oxygen dissolves proportionally with its partial pressure throughout HBO administration (9) . Moreover, it has been shown that HBO modulates antioxidant enzymes such as superoxide dismutase and glutathione peroxidase in rat erythrocytes (10) .
HBO therapy dating back to the 17th century is widely used in modern medicine in the treatment of many diseases. Many clinical problems such as chronic nonhealing wounds, burns, air and gas embolism and decompression sickness, and carbon monoxide poisoning can be treated this way (11) (12) (13) .
Based on these data, HBO administration may be a novel approach to improve vital parameters of stored blood by providing oxygen delivery for blood constituents. In this study, we aimed to evaluate the likely potential efficiency in improving quality of stored blood and to introduce a new utilization area for hyperbaric oxygen.
Materials and methods

Subjects and samples
In this study, blood samples obtained from the same persons were used as both control and HBO groups. Eight male volunteers (mean age: 35.4 ± 2.9 years) were included in the study for blood samples. Volunteers were chosen from healthy people who had no diseases and had not used any drugs for the last week before blood sample harvesting. Written consent was provided by each of the volunteers. Three hundred milliliters of whole blood was obtained intravenously under optimal conditions. All donors' routine blood parameters were within normal limits (Table 1) . The blood samples were divided into 2 pediatric bags (2 × 150 mL) suitable for gas diffusion and stored with 35 mL of citrate-phosphate-dextrose (CPD) solution at 4 °C until analysis. One of the bags was used as the control and the other as the HBO exposure group.
Administration of hyperbaric oxygen
Starting 24 h after blood collection, HBO was administered every 48 h and continued for a total of 10 sessions (days 1, 3, 5, 7, 9, 11, 13, 15, 17, and 19) . For this purpose, blood bags of the HBO group were placed in a special hyperbaric chamber (made at the Etimesgut Military Equipment Factory, Ankara, Turkey), and then HBO administrations were performed. For safety reasons, the Undersea & Hyperbaric Medical Society (UHMS) limits the use of HBO for living organisms with a maximal pressure and duration range of 3 atmospheres absolute (ATA) and 2 h. At exposures of 2-2.5 ATA for 1-1.5 hours, almost no side effects were reported (14) . We therefore chose an HBO administration procedure of 2.5 ATA for 90 min. Since CPD is known to preserve blood for 3 weeks, the study was terminated at the 21st day (48 h after the final HBO session).
Sample analysis
The first blood analyses were performed on the day of blood collection independent of the bag's content, and then 10-mL samples were taken from bags on days 7 (before HBO administration), 14 and 21. The following parameters were measured:
-Serum pH and glucose levels.
-Serum potassium (K + ) and lactate dehydrogenase (LDH) values.
-Erythrocyte membrane strength (osmotic fragility test). -Red blood cells and indexes: red blood cell count (RBC), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red blood cell distribution width (RDW), hemoglobin, and hematocrit.
-Platelets and clotting functions: platelet cell count, mean platelet volume (MPV), platelet distribution width (PDW), prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR).
-White blood cell count (WBC).
Statistical analysis
For statistical analysis, SPSS 16.0 (SPSS Inc., Chicago, IL, USA) was used, and all parameters were presented as mean ± standard error of mean. Alterations of measured parameters were evaluated in curves and the KruskalWallis test was followed by post hoc Wilcoxon (for timedependent changes within the same group) and MannWhitney U (for group-to-group comparisons) tests. P-values of less than 0.05 were assessed as significant.
Results
Both MCV and MPV tended to increase with time in the control and HBO-exposed blood samples ( Table 2 ). The increased MCVs were found to be significantly different from the initial day 0 level (P = 0.24 for day 7 of control group, P = 0.12 for others), except on day 7 of the HBO group (P = 0.079). On the other hand, MPV values of HBO group were significantly higher than their respective controls of the same study day (P = 0.015, 0.004, and 0.023 at days 7, 14, and 21, respectively). The MPVs of days 7 and 14 in the HBO group were not significantly different from day 0 values (P = 0.916 and 0.139, respectively). Eventually, HBO exposure slowed down the increase in volumes of erythrocytes and platelets ( Figure 1 ).
Due to being mixed with the CPD content of the bags, plasma glucose levels were found to be increased on day 7 compared to the initial levels (P = 0.12 for both control and HBO groups). The glucose levels then decreased with time. On day 14, the glucose level of the HBO group still remained significantly higher than the respective initial value (P = 0.012 compared to day 0) and was also found to be significantly higher than that of the control group (P = 0.046 compared to day 7 value of control group) (Figure 2) . Table 3 represents the entire blood glucose measurements of the study. With respect to osmotic fragility, statistically significant results were obtained at various concentrations: on day 7, the HBO-exposed group presented more stable erythrocyte membranes at 0.5% and 0.45% NaCl concentrations (P = 0.27 and 0.46 compared to control group, respectively), and on day 21, the osmotic fragility of the HBO-exposed group was lower at 0.55% and 0.5% NaCl concentrations (P = 0.46 and 0.16 compared to the control group, respectively) ( Figure 3) . Table 3 presents the entire numeric outcome for osmotic fragility measurements.
As expected, pH levels decreased in both groups with time. Although not significantly different, the fall of pH in the control group was slightly more than in the HBO group (Table 4) . None of the other measured parameters (clotting functions, hemolysis indices) reflected any statistical difference between HBO and control groups; however, decreased or increased values with regard to the nature of the measured value were recorded (Tables 5 and  6 ). HBO exposure neither improved nor worsened clotting functions or the hemolysis rate of stored blood. . Plasma glucose levels of stored blood samples. Due to the dextrose content, glucose levels increased initially and were found significantly higher than day 0 values on day 7 in both groups. Glucose levels then started to decline; on day 14 the glucose concentration of the HBO group was still significantly higher than control and day 0 values. P < 0.05 compared to (a) control group and (b) day 0. Figure 3 . Erythrocyte osmotic fragility (ratio to absorbance in distilled water). As expected, osmotic fragility increased with storage time. The increase in control bloods was higher than in HBO-exposed bloods at all measured points. P < 0.05 compared to (a) control group and (b) day 0.
Discussion
HBO has its effects by 2 major mechanisms in the body. The first is a mechanical effect that occurs on gascontaining voids and air bubbles with high pressure. The dissolution of gas is provided by a reduction of gas volume with this effect. Another mechanism is based on increasing the amount of dissolved oxygen in the plasma. In this way, oxygenation of tissues is provided without requiring hemoglobin. These 2 mechanisms constitute the basis of HBO administration for treatment (15, 16) . Erythrocytes in bone marrow pass into circulation without nuclei or mitochondria. Thus, glucose is the main energy source for erythrocytes. As a result of this, erythrocytes maintain viability via the glycolytic pathway and consequently synthesize various end products such as pyruvate, lactate, and ATP with acidic properties. These acidic compounds are responsible, at least in part, for the reduction in plasma pH (17) . Second, anticoagulant agents present in blood bags are also responsible for the decrease of pH. The changes in lactate and pH values can potentially lead to various complications in patients with renal and hepatic pathologies, and in pediatric and senile patients (18, 19) . Generally, a high concentration of dextrose is added to blood preservation solutions (as it is in CPD) in order to support erythrocyte metabolic processes; therefore, an increased glucose concentration at the initial state of blood storage is expected (18) . After this initial rise, plasma glucose levels decrease in correlation with storage time (20) . Citrate, another component of CPD solution, also causes reduction the pH value (21) . In the present study, a clear decrease of the pH levels was recorded in both the HBO and the control group (Table  3) . The pH levels of the HBO group presented slightly higher values than those of the control bags; however, the difference was not significant. On the other hand, HBO administration supported the glucose content of the bags, Table 5 . Evaluation of clotting functions (mean ± SD). INR, international normalized ratio; PT, prothrombin time; aPTT, activated plasma thromboplastin time. Table 6 . Evaluation of hemolysis rate (mean ± SD). resulting in a statistically significant difference between the study groups on day 14. Glucose was consumed less in the HBO than the control group and so the slightly higher pH values of the HBO group became more significant. It has been shown that a number of changes, such as increase in serum LDH levels and potassium, occur in stored blood over the course of time; intracellular potassium leaks outside the erythrocytes due to failure of the Na + /K + -ATPase pump. In addition, factor V and VIII activities start to decrease and result in impaired or prolonged clotting function (5, 6) . Excessive working of active pumps during storage causes a reduction in levels of ATP, which is also required for the protection of erythrocytes' shape and membrane stability. Eventually, these changes cause reduction in erythrocyte viability (22) .
The osmotic fragility test is an analysis related to erythrocyte shape and the surface-to-volume ratio and shows the sensitivity of erythrocytes to hypotonic conditions. Fresh blood has lower osmotic fragility than stored blood with different methods. Therefore, resistance of erythrocyte membranes in stored blood weakens and erythrocytes become more fragile day by day (18) . The osmotic impact of accumulated lactate may also be considered as another reason for the increase in osmotic fragility (23) . Indeed, activity in donor circulation of erythrocytes in stored blood is related to membrane stability of transfused erythrocytes and its ability to function. Reduction in cellular ATP levels increase membrane rigidity and lead to loss of membrane flexibility. Alterations in volume and volume/surface ratio may be associated with loss of surface area as a result of accumulation of osmotic substances such as lactate. The alterations in osmotic fragility are also related to plasma pH and the osmolarity of the preservative solution. In addition, high dextrose contents of preservative solutions may be responsible for the increase in osmotic fragility (24) . The present study provides evidence for both supporting the osmotic stability of erythrocyte membranes (Table 4) and preventing the cellular volume expansion (Table 2) with HBO administration to stored blood bags. The increase in MCV and MPV was less than that of control bags in the HBO-exposed group, with a significant difference for MPV at day 21. In addition, the erythrocytes' membranes in the HBO group reflected significantly less fragility to osmotic forces.
The present study showed that HBO administration has the ability to decrease glucose consumption, maintain pH values closer to initial levels, and support erythrocyte membrane strength. In addition, the rate of increase in MCV was less than expected. Since fundamental indicators of erythrocyte viability are membrane functions, cellular metabolism, and shape, these results are of particular importance. Previous studies conducted in our laboratory provided evidence for induction of endogenous antioxidant enzymes in erythrocytes with HBO exposure (10) . A possible mechanism for the present results may be the reduction of free radical production via induction of antioxidant enzyme systems, which would support physiologic function of the Na + /K + -ATPase pump. Almost all recorded signs, such as reduction of glucose consumption, maintenance of pH values, and membrane strength, as well as erythrocyte volume, indicate less energy consumption and reduced energy requirements, which eventually leads to less cell damage.
On the other hand, increase in MPV indicates increased activation of platelets and is an independent predictor for the risk of cardiovascular diseases (25) . In the present study, the increase in MPV was significantly less than in control blood in the HBO-exposed group (Table  2) . This condition suggests less clotting tendency in the case of use for transfusion and may reduce posttransfusion complications.
The relatively low case number (n = 8 for each group) must be mentioned as a limitation of this work, which seems to be responsible for some of the statistically insignificant differences. In this regard, future studies with greater sample size and alternative HBO regimens (daily, twice daily, pressure/duration modifications, or even 'normobaric' instead of 'hyperbaric' oxygen administration) would help clarify the present pilot (preliminary) results. Studies concentrated on the metabolism and energy mechanisms of the cells should also be conducted.
In conclusion, the present study provided relatively positive results on some stored blood viability indices with HBO administration. The main outcome can be summarized as supporting the energy source (glucose), lessening the fall of pH, and stabilizing erythrocyte and platelet membranes. Without a doubt, these results can be interpreted for the benefit of the shelf life of stored blood.
